Axogen, Inc. (AXGN) Scorecard
- 2026-Q2: Total return Win; Revenue growth Win; EPS growth Win.
- 2026-Q1: Total return Win; Revenue growth Win; EPS growth Win.
- 2025-Q4: Total return Win; Revenue growth Win; EPS growth Win.
- 2025-Q3: Total return Win; Revenue growth Win; EPS growth Lose.
63/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 11 wins, 1 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q23/3 |
WinAXGN / S&P 39.42% / 15.20% |
WinAXGN / S&P 23.57% / 15.00% |
WinAXGN / S&P 580.00% / 50.40% |
| 2026-Q13/3 |
WinAXGN / S&P 1.22% / -4.33% |
WinAXGN / S&P 22.41% / 11.30% |
WinAXGN / S&P 326.67% / 27.70% |
| 2025-Q43/3 |
WinAXGN / S&P 83.46% / 2.65% |
WinAXGN / S&P 20.21% / 9.00% |
WinAXGN / S&P 54.55% / 13.40% |
| 2025-Q32/3 |
WinAXGN / S&P 64.42% / 8.12% |
WinAXGN / S&P 18.72% / 4.61% |
LoseAXGN / S&P -84.38% / 13.45% |
| 2025-Q21/3 |
LoseAXGN / S&P -41.35% / 10.94% |
WinAXGN / S&P 17.17% / 4.83% |
LoseAXGN / S&P -73.68% / 10.63% |
| 2025-Q12/3 |
WinAXGN / S&P 12.26% / -4.27% |
WinAXGN / S&P 18.81% / 4.98% |
LoseAXGN / S&P -70.00% / 10.57% |
| 2024-Q42/3 |
WinAXGN / S&P 17.55% / 2.41% |
WinAXGN / S&P 17.81% / 5.25% |
LoseAXGN / S&P -57.69% / 6.15% |
| 2024-Q32/3 |
WinAXGN / S&P 93.65% / 5.89% |
WinAXGN / S&P 18.79% / 5.89% |
LoseAXGN / S&P -42.86% / 6.11% |
| 2024-Q21/3 |
LoseAXGN / S&P -10.29% / 4.28% |
WinAXGN / S&P 17.26% / 5.38% |
LoseAXGN / S&P -32.14% / 5.12% |
| 2024-Q12/3 |
WinAXGN / S&P 18.16% / 10.56% |
WinAXGN / S&P 13.51% / 5.71% |
LoseAXGN / S&P -13.79% / 5.59% |
| 2023-Q42/3 |
WinAXGN / S&P 36.60% / 11.69% |
WinAXGN / S&P 14.74% / 6.81% |
LoseAXGN / S&P -23.53% / 7.78% |
| 2023-Q31/3 |
LoseAXGN / S&P -45.24% / -3.27% |
WinAXGN / S&P 13.66% / 7.52% |
LoseAXGN / S&P -16.42% / -5.03% |
| 2023-Q21/3 |
LoseAXGN / S&P -3.39% / 8.74% |
WinAXGN / S&P 15.40% / 9.50% |
LoseAXGN / S&P -24.32% / -8.57% |
| 2023-Q11/3 |
LoseAXGN / S&P -5.31% / 7.50% |
WinAXGN / S&P 13.28% / 10.77% |
LoseAXGN / S&P -22.67% / -15.69% |
| 2022-Q41/3 |
LoseAXGN / S&P -16.28% / 7.56% |
LoseAXGN / S&P 8.81% / 11.88% |
WinAXGN / S&P 6.25% / -17.99% |
| 2022-Q32/3 |
WinAXGN / S&P 45.54% / -4.88% |
LoseAXGN / S&P 4.40% / 13.47% |
WinAXGN / S&P 0.00% / -1.41% |
| 2022-Q22/3 |
WinAXGN / S&P 3.15% / -16.10% |
LoseAXGN / S&P -1.79% / 13.71% |
WinAXGN / S&P 37.04% / 11.04% |
| 2022-Q10/3 |
LoseAXGN / S&P -15.26% / -4.60% |
LoseAXGN / S&P 6.93% / 15.97% |
LoseAXGN / S&P 36.36% / 42.23% |
| 2021-Q40/3 |
LoseAXGN / S&P -40.70% / 11.03% |
LoseAXGN / S&P 13.41% / 15.00% |
LoseAXGN / S&P AXGN unavailable / 96.40% |
| 2021-Q31/3 |
LoseAXGN / S&P -26.89% / 0.58% |
WinAXGN / S&P 18.85% / 10.77% |
LoseAXGN / S&P AXGN unavailable / 69.42% |
| 2021-Q21/3 |
LoseAXGN / S&P 6.66% / 8.55% |
WinAXGN / S&P 26.61% / 6.58% |
LoseAXGN / S&P AXGN unavailable / 51.81% |
| 2021-Q12/3 |
WinAXGN / S&P 13.18% / 6.17% |
WinAXGN / S&P 10.57% / -1.06% |
LoseAXGN / S&P AXGN unavailable / 7.39% |
| 2020-Q42/3 |
WinAXGN / S&P 53.91% / 12.15% |
WinAXGN / S&P 5.24% / -3.72% |
LoseAXGN / S&P AXGN unavailable / -33.42% |
| 2020-Q32/3 |
WinAXGN / S&P 25.87% / 8.93% |
WinAXGN / S&P 5.87% / -2.04% |
LoseAXGN / S&P AXGN unavailable / -27.10% |
| 2020-Q21/3 |
LoseAXGN / S&P -11.15% / 20.54% |
WinAXGN / S&P 7.31% / -0.46% |
LoseAXGN / S&P AXGN unavailable / -27.11% |
| 2020-Q11/3 |
LoseAXGN / S&P -41.87% / -19.60% |
WinAXGN / S&P 19.70% / 3.47% |
LoseAXGN / S&P AXGN unavailable / -14.75% |
| 2019-Q42/3 |
WinAXGN / S&P 43.35% / 9.07% |
WinAXGN / S&P 27.13% / 5.36% |
LoseAXGN / S&P AXGN unavailable / 2.99% |
| 2019-Q31/3 |
LoseAXGN / S&P -36.97% / 1.70% |
WinAXGN / S&P 31.63% / 5.02% |
LoseAXGN / S&P AXGN unavailable / 0.21% |
| 2019-Q21/3 |
LoseAXGN / S&P -5.98% / 4.30% |
WinAXGN / S&P 35.59% / 6.64% |
LoseAXGN / S&P AXGN unavailable / 8.65% |
| 2019-Q11/3 |
LoseAXGN / S&P 3.08% / 13.65% |
WinAXGN / S&P 37.46% / 8.12% |
LoseAXGN / S&P AXGN unavailable / 14.29% |
| 2018-Q41/3 |
LoseAXGN / S&P -44.56% / -13.52% |
WinAXGN / S&P 38.91% / 9.05% |
LoseAXGN / S&P AXGN unavailable / 18.23% |
| 2018-Q31/3 |
LoseAXGN / S&P -26.67% / 7.71% |
WinAXGN / S&P 41.21% / 10.21% |
LoseAXGN / S&P AXGN unavailable / 19.06% |
| 2018-Q22/3 |
WinAXGN / S&P 37.67% / 3.43% |
WinAXGN / S&P 41.66% / 9.03% |
LoseAXGN / S&P AXGN unavailable / 14.46% |
| 2018-Q12/3 |
WinAXGN / S&P 28.98% / -0.76% |
WinAXGN / S&P 44.67% / 7.68% |
LoseAXGN / S&P AXGN unavailable / 12.46% |
| 2017-Q42/3 |
WinAXGN / S&P 46.25% / 6.64% |
WinAXGN / S&P 46.99% / 7.03% |
LoseAXGN / S&P AXGN unavailable / 13.82% |
| 2017-Q32/3 |
WinAXGN / S&P 15.52% / 4.48% |
WinAXGN / S&P 46.28% / 5.68% |
LoseAXGN / S&P AXGN unavailable / 17.57% |
| 2017-Q22/3 |
WinAXGN / S&P 60.29% / 3.09% |
WinAXGN / S&P 45.18% / 4.83% |
LoseAXGN / S&P AXGN unavailable / 17.74% |
| 2017-Q12/3 |
WinAXGN / S&P 16.11% / 6.07% |
WinAXGN / S&P 48.36% / 3.67% |
LoseAXGN / S&P AXGN unavailable / 13.32% |
| 2016-Q41/3 |
LoseAXGN / S&P -0.33% / 3.82% |
WinAXGN / S&P 50.41% / 2.09% |
LoseAXGN / S&P AXGN unavailable / 7.05% |
| 2016-Q32/3 |
WinAXGN / S&P 31.25% / 3.85% |
WinAXGN / S&P 54.25% / 0.20% |
LoseAXGN / S&P AXGN unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | AXGN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 220.51% | 20.78% |
| Annualized return | 220.51% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | AXGN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 197.98% | 83.14% |
| Annualized return | 24.41% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | AXGN total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 475.42% | 319.30% |
| Annualized return | 19.12% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |